Christopher B. Jones, MD

Make an Appointment
Christopher B. Jones
Department of Medicine
Western Hematology-Oncology
Northern Hematology-Oncology
Division of Oncology
Christopher B. Jones, MD, is an oncologist at National Jewish Health. Dr. Jones is in the Division of Oncology and Department of Medicine.

image descriptionPrograms & Services
Specialties and ConditionsSpecialties & Conditions
Research AreasResearch Areas
  • Medical Oncology

Special Interests

I am a clinical hematology/oncology physician. I see all types of hematologic disorders and every type of cancer. I am interested in cooperative group oncology clinical trials to promote best practice in oncology to achieve optimal results.

Education

Education
University of Miami School of Medicine, Miami, FL,
Residency
Tripler Army Medical Center, Tripler, HI, Internal Medicine
Fellowship
Brooke Army Medical Center, Ft. Sam Houston, TX, Hematology/Oncology

Awards & Recognition

2005-2006: UTHSCA Outstanding Faculty Award for 3rd year Medical Student
2005: Bronze Star, Operation Iraqi Freedom II
2000: William J Uphouse Award for most compassionate physician
 

Board Certification

2003: Medical Oncology
2003: Hematology
2000: Internal Medicine

Professional Memberships

ASCO
American Society Hematology

Publications

Schwartz Garry H and Jones Christopher B. et al. A Phase I and Pharmacokinetic Study of Non-polyglutamatible Thymidylate Synthase Inhibitor ZD9331 and Docetaxel in Patients with Advanced Solid Malignancies. Investigational New Drugs 22: 437-448, 2004.

Mita AC, Hammond LA, Jones CB et al. Phase I and Pharmacokinetic Study of Tasidotin Hydrochloride (ILX651), a Third Generation Dolastatin-15 Analogue, Administered Weekly for 3 Weeks Every 28 Days in Patients with Advanced Solid Tumors. Clinical Cancer Research. 12: 5207-5215, 2006.

R.F. Setlik, G. Preston, C.B Jones et al. A Phase I Study of the Effects of Hepatic Impairment on the Pharmacokinetic (PK) and Safety of Satraplatin in Patients with Refractory Non-Hematologic Cancer. ASCO Clinical Proceedings, Abstract #2045, 2006

Shumway NM, Jones CB, and Terrazzino S. Randomized pilot study comparing aprepitant to olanzapine for treatment of chemotherapy-induced nausea and vomiting. ASCO Clinical Proceedings, Abstract 9633, 2009

Teaching & Professional Positions

2013-2015: Levine Cancer Institute, Leukemia Committee
2013-2015: Levine Cancer Institute, Upper/Lower GI Cancer Committee
2013-2015: Levine Cancer Institute, Genetic Committee
2007-2008: Chief, Hematology/Oncology Services, Brooke Army Medical Center
2006-2008: Assistant Program Director, SAUSWEC Hematology/Oncology Fellowship
2004-2005: Chief Medical Services, 115th Field Hospital

Ask a Question through Patient Portal

Sign in to your My National Jewish Health patient portal account to communicate with your care team, manage appointments, and more. Create an Account
 

Contact Information

  • Office: 303.650.4042 or 303.232.0602
  • Fax: 303.650.4046 or 303.988.8750
  • Alternate: 877.225.5654

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our independent rating system, the Press Ganey Patient Satisfaction Survey.

Responses are measured on a scale of 1 to 5, with 5 being the best score. Learn more about our patient satisfaction survey.
 
 

Comments

Comments are collected in our Press Ganey Patient Satisfaction Surveys. Patients are de-identified to protect confidentiality and patient privacy. Learn more about our patient satisfaction survey.